Isansys Shortlisted for Best Established Medtech Company Award

Isansys Lifecare will find out next month if it has won the title of Best Established Medtech Company at the prestigious 2021 OBN Awards.

The company, based in Oxfordshire, was shortlisted for the development of its Patient Status Engine (PSE), an advanced patient monitoring platform that collects and analyses patients’ vital signs and helps inform healthcare decisions.

The PSE represents a revolutionary step in the rapidly growing area of digital healthcare. It is a unique platform–as-a-medical-device, which provides 24/7 surveillance of patients. By automatically and continuously collecting and analysing patient data, the system provides intelligent alerts and early warnings to clinical staff to allow them to make earlier and simpler interventions and thus prevent many avoidable and costly adverse events, regardless of whether the patients are in hospital or at home.

Keith Errey, CEO of Isansys, said: “We are delighted to have been shortlisted for this award in recognition of our ground-breaking and innovative work. This is a shining example of how Isansys is gaining wider recognition for the benefits our Patient Status Engine monitoring platform brings to hospitals and healthcare providers across the world.

“Our digital healthcare technology is delivering huge efficiencies to healthcare organisations, improving patient outcomes and preventing avoidable deaths in the midst of a global healthcare crisis.”

OBN, a not-for-profit business network, provides support to innovative life sciences companies, corporate partners and investors in the UK. This year makes the 13th anniversary of its annual awards which celebrate and recognise achievements in the industry.

The winners will be announced on Thursday, November 25, at a ceremony at the Ashmolean Museum in Oxford.

For more information about the OBN awards and the full list of winners, please visit: https://obn.glueup.com/event/obn-awards-2021-43912/